Finance

Beta
Lists
LXEO:NASDAQ
Lexeo Therapeutics Inc
$4.37
-8.58%
(-0.41) 1D
$4.28
-2.04% (-0.089)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
$4.77
High
$4.78
Low
$4.34
Mkt. cap
343.14M
Avg. vol.
724.16K
Volume
465.60K
52-wk high
$10.99
52-wk low
$3.30
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
Open
$4.77
High
$4.78
Low
$4.34
Mkt. cap
343.14M
Avg. vol.
724.16K
Volume
465.60K
52-wk high
$10.99
52-wk low
$3.30
EPS
-$1.45
Shares outstanding
78.52M
No. of employees
59
Analyst outlook
Analyst Ratings
Based on 5 analysts giving stock ratings to LXEO in the past 3 months
Strong Buy
Buy
5
Hold
0
Sell
0
12 month forecast
Based on 5 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current $4.37
$20.00 (+357.67%)
Average
$18.60 (+325.63%)
Lowest
$17.00 (+289.02%)
News stories
From sources across the web
About Lexeo Therapeutics Inc
CEO-
Employees59
Founded2017
Headquarters-
SectorBiotechnology
Websitelexeotx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
14.72M
15.70M
16.21M
15.70M
Cost of revenue
14.72M
15.70M
16.21M
15.70M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.97M
5.95M
6.91M
6.63M
Operating expense
15.97M
5.95M
6.91M
6.63M
Total operating expenses
30.69M
21.65M
23.12M
22.33M
Operating income
-30.69M
-21.65M
-23.12M
-22.33M
Other non operating income
-14.00K
-9.00K
9.00K
-1.00K
EBT including unusual items
-26.10M
-20.28M
-20.92M
-20.20M
EBT excluding unusual items
-29.46M
-20.22M
-20.91M
-20.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.10M
-20.28M
-20.92M
-20.20M
Net profit margin
-
-
-
-
Earnings per share
-0.68
-0.33
-0.27
-0.25
Interest and investment income
1.27M
1.46M
2.21M
2.11M
Interest expense
-25.00K
-22.00K
-20.00K
-17.00K
Net interest expenses
1.24M
1.43M
2.19M
2.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.55M
-21.50M
-22.96M
-22.18M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer